Videos

This is the last day of a joint meeting of the FDA’s Arthritis and Drug Safety and Risk Management Advisory Committees. At the end of the three-day forum the 32-member panel had recommended …

At a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, experts discussed the safety of arthritis drugs called “COX-2” inhibitors. Dr. Anne Trontell gave…

At a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, members discussed the safety of drugs called “COX-2” inhibitors, such as Vioxx and Celebrex. Dr. …

The Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees continued discussions in their joint meeting on possible safety of risks of “COX-2” inhib…

Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Drug Administration spoke about a number of issues in…

Dr. Villalba and others spoke at a meeting to assess the safety records of arthritis drugs. They talked about testing and approval of the drug Vioxx and its subsequent use by American consum…

Health experts and industry lobbyists debated the extent to which prescription drugs should be converted to “over the counter” status. They also talked about the sometimes blurry line betwee…